GRAIL, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-18 meeting.
“The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The proposal received the following votes: Votes For Votes Against Abstentions Broker Non-Votes 34,611,318 57,682 407,394 0”
Shareholder Votes
GRAIL, Inc. shareholders approved Election of two Class II Directors to serve until the Annual Meeting of Stockholder to be held in 2029 and until their successors are duly elected and qualified at the 2026-06-18 meeting.
“The Company’s stockholders elected two Class II Directors to serve until the Annual Meeting of Stockholder to be held in 2029 and until their successors are duly elected and qualified. The votes regarding the election of the directors were as follows: Name Votes For Withheld Broker Non-Votes Sarah Krevans 18,929,398 2,972,804 13,174,192 Steven Mizell 16,998,081 4,904,121 13,174,192”
Joshua Ofman was appointed as Chief Executive Officer at GRAIL, Inc..
“Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers In connection with Dr. Joshua Ofman’s appointment as the Chief Executive Officer of GRAIL, Inc. (the “Company”), on June 1, 2026, the Company’s board of directors (the “Board”) approved an amended and restated offer letter (the “Amended Offer Letter”) and authorized and directed the Company to enter into such Amended Offer Letter with Dr. Ofman, with the Amended Offer Letter effective as of June 1, 2026 (the “Effective Date”).”
Earnings Releases
GRAIL, Inc. reported first quarter ended March 31, 2026 results: revenue $40.8 million, net income $(93.2) million.
“GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the first quarter of 2026. Total revenue in the first quarter grew 28% year over year to $40.8 million, and Galleri revenue grew 37% year-over-year to $39.8 million. Galleri test volume for the quarter grew 50% year-over-year to more than 56,000. Net loss for the quarter was $93.2 million.”
Equity Issuances
GRAIL, Inc. issued prefunded warrants to purchase shares of Common Stock of warrant to the purchasers named therein (the "Investors") for $70.05 per Share (or per Pre-Funded Warrants in lieu thereof, less the nominal exercise price of $0.001 per share).
“prefunded warrants to purchase shares of Common Stock, with an exercise price of $0.001 per share (the “Pre-Funded Warrants”), at a price of $70.05 per Share (or per Pre-Funded Warrants in lieu thereof, less the nominal exercise price of $0.001 per share)”
Equity Issuances
GRAIL, Inc. issued 4,639,543 shares of common stock to the purchasers named therein (the "Investors") for $70.05 per Share.
“investors in lieu of Common Stock, prefunded warrants to purchase shares of Common Stock, with an exercise price of $0.001 per share (the “Pre-Funded Warrants”), at a price of $70.05 per Share (or per Pre-Funded Warrants in lieu thereof, less the nominal exercise price of $0.001 per share) for aggregate gross proceeds of approximately $325.0 million, before”
Equity Issuances
GRAIL, Inc. issued 1,570,308 shares of common stock of common stock to Samsung C&T Corporation and Samsung Electronics Singapore Pte. Ltd. for $70.05 per share.
“On October 16, 2025, GRAIL, Inc. (the “Company”) entered into a stock purchase agreement (the “Stock Purchase Agreement”), by and among the Company, Samsung C&T Corporation (“Samsung C&T”), Samsung Electronics Singapore Pte. Ltd. (“Samsung Electronics Singapore” and together with Samsung C&T, the “Samsung Investors”) and Samsung Electronics Co., Ltd. (“Samsung Electronics”), providing for the issuance and sale by the Company to the Samsung Investors in a private placement of an aggregate of 1,570,308 shares of common stock, par value $0.001 per share (the “Shares”), at a purchase price of $70.05 per share”
Debt Financings
GRAIL, Inc. incurred lease obligation with Sunnyvale Office Acquisition, LLC maturing September 30, 2037.
“On September 11, 2025, GRAIL, Inc. (the “Company”) entered into a commercial lease agreement (the “Lease”) with Sunnyvale Office Acquisition, LLC pursuant to which the Company agreed to lease an aggregate of approximately 75,556 rentable square feet for a new corporate headquarters located at 250 S. Matilda Avenue in Sunnyvale, California.”
Sarah Krevans was appointed as Director at GRAIL, Inc..
“On October 21, 2024, the Board of Directors (the “Board”) of GRAIL, Inc. (the “Company”) appointed Sarah Krevans to the Board, effective immediately.”
Restructurings & Charges
GRAIL, Inc. announced a impairment with charges of approximately $420.0 million affecting IPR&D intangible assets.
“Illumina disclosed that it expects to recognize an impairment charge for IPR&D intangible assets of approximately $420.0 million in connection with the Spin-Off, and such charge will also be pushed down to the Company and recorded in the second quarter”
Restructurings & Charges
GRAIL, Inc. announced a impairment with charges of $888.9 million affecting goodwill.
“the Company estimates that it will recognize a goodwill impairment charge in the second quarter of 2024 equal to $888.9 million, or the full remaining carrying value of goodwill as of March 31, 2024”
M&A Transactions
GRAIL, Inc. underwent a change of control involving Illumina, Inc. for pro rata distribution of 85.5% of outstanding shares of GRAIL common stock to Illumina stockholders (closed 2024-06-24).
“the “Company,” “we,” “us” or “our”) from Illumina, Inc. (“Illumina”) was completed. The Separation of GRAIL from Illumina was achieved through Illumina’s pro rata distribution of 85.5% of the outstanding shares of GRAIL common stock to holders of record of Illumina common stock as of the close of business on June 13, 2024 (the “Record Date”). Each holder of”
Gregory (Greg) Summe was appointed as Chair of the Board at GRAIL, Inc..
“Mr. Summe was appointed as the Chair of the Board”
Josh Ofman was appointed as President at GRAIL, Inc..
“Josh Ofman President”
Aaron Freidin was appointed as Chief Financial Officer at GRAIL, Inc..
“Aaron Freidin Chief Financial Officer”
Robert Ragusa was appointed as Chief Executive Officer at GRAIL, Inc..
“Robert Ragusa Chief Executive Officer”
Robert Ragusa was appointed as Director at GRAIL, Inc..
“William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.”
Gregory (Greg) Summe was appointed as Director at GRAIL, Inc..
“William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.”
Steve Mizell was appointed as Director at GRAIL, Inc..
“William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.”
William (Bill) Chase was appointed as Director at GRAIL, Inc..
“William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.”
William (Bill) Chase departed as Director at GRAIL, Inc..
“Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.”
Ankur Dhingra departed as Director at GRAIL, Inc..
“Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.”
Charles Dadswell departed as Director at GRAIL, Inc..
“Charles Dadswell, Ankur Dhingra and William (Bill) Chase ceased to be directors of GRAIL, LLC, the Company’s predecessor.”
William Chase was appointed as Director at GRAIL, Inc..
“Effective June 11, 2024, Illumina, Inc., as sole member of GRAIL, LLC (the “Company”), established a board of directors of the Company (the “Board”) and appointed each of Charles Dadswell, Ankur Dhingra and William (Bill) Chase (together, the “Directors”) to the Board.”
Ankur Dhingra was appointed as Director at GRAIL, Inc..
“Effective June 11, 2024, Illumina, Inc., as sole member of GRAIL, LLC (the “Company”), established a board of directors of the Company (the “Board”) and appointed each of Charles Dadswell, Ankur Dhingra and William (Bill) Chase (together, the “Directors”) to the Board.”
Charles Dadswell was appointed as Chair of the Board at GRAIL, Inc..
“Effective June 11, 2024, Illumina, Inc., as sole member of GRAIL, LLC (the “Company”), established a board of directors of the Company (the “Board”) and appointed each of Charles Dadswell, Ankur Dhingra and William (Bill) Chase (together, the “Directors”) to the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.